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Abstract Neuropathy target esterase (NTE) is a novel
phospholipase B and plays a role in phospholipid homeo-
stasis. Although over-expression of NTE inhibits cell
division, the role of NTE in cell proliferation is still
unknown. In the current study, we firstly used synchronous
HeLa cells to study the expression profile of NTE during
the cell cycle. NTE protein and activity are regulated
during the cell cycle with highest level at G1 and lowest at
G2/M phase. However, NTE mRNA levels are constant
during the cell cycle. The role of NTE in cell proliferation
was investigated by short hairpin RNA (shRNA) to sup-
press the expression of NTE. Knockdown of NTE signifi-
cant down-regulated of NTE expression and reduced the
glycerophosphocholine level. However, suppression of
NTE did not affect phosphatidylcholine content or cell
cycle progression. In addition, NTE was demonstrated to
be degraded by the ubiquitin-proteasome pathway. These
results suggested for the first time that NTE is a cell cycle-
dependent protein, but is not essential for cell proliferation,
and the ubiquitin-mediated proteolysis may be involved in
the regulation of NTE during the cell cycle.
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Introduction
Neuropathy target esterase (NTE) was identified over
40 years ago as the primary target of organophosphorus
compounds (OP) that cause a delayed paralyzing syndrome
with degeneration of nerve axons [1]. Although the inhi-
bition and subsequent aging of NTE has been proposed to
be an initiating event in OP-induced delayed neuropathy
(OPIDN), the events that occur between NTE inhibition
and the appearance of clinical pathology are not completely
understood [2].
As a polypeptide of 1,327 amino acids, NTE is anchored
to the cytoplasmic face of endoplasmic reticulum (ER)
through an amino-terminal transmembrane segment in
mammalian cells [3, 4]. NTE displayed potent lysophos-
pholipase activity in mouse brain and further characterized
as a novel phospholipase B (PLB) responsible for converting
CDP–choline pathway-synthesized phosphatidylcholine
(PC) to glycerophosphocholine (GPC) in mammalian cells
and regulating PC homeostasis in Drosophila and mouse
[5–8]. Complete inactivation of mouse NTE gene resulted in
embryonic lethality due to placental failure and impaired
vasculogenesis [9, 10]. In addition, mice with a brain specific
deletion of NTE exhibited neurodegenerative diseases
characterized by vacuolization and neuronal loss and distal
degeneration of the longest spinal axons [4, 8]. Moreover,
loss of swiss cheese/NTE activity also caused neuronal and
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glial death in adult Drosophila [7]. Recently, disease-specific
and nonconserved NTE mutations were found in unrelated
motor neuron disease patients [11]. Thus, NTE is essential
for neural development and axonal maintenance.
PC is the most abundant phospholipid and predomi-
nantly uses the CDP-choline pathway to synthesize PC in
eukaryotic membranes and mammalian cells. The homeo-
stasis between synthesis and turnover of PC is required for
cell division and creation of new membranes [12]. More-
over, the disturbances in PC metabolism have been asso-
ciated with cell growth arrest [13]. Previous studies showed
that general membrane phospholipid homeostasis was
achieved by balancing the opposing activities of CTP-
phosphocholine cytidylyltransferase (CCT) and calcium-
independent phospholipase A2 (iPLA2) [14–16]. However,
it was reported that over-expression of NTE increased GPC
production, which was offset by reduced choline uptake
and incorporation into CDP-choline, suggesting a homeo-
static coupling with CCT and regulation of PC level for
NTE in mammalian cells [6].
As a PLB, disturbance of NTE may disturb PC
homeostasis and have an effect of cell proliferation.
Indeed, it has been demonstrated that the relatively modest
degree (approximately 2-fold) of GPC production was
increased in cells over-expressing NTE and inhibited nor-
mal cell division [6]. Furthermore, our previous results
showed that over-expression of NTE inhibited both non-
neural cells, such as monkey kidney COS7 cells, and neural
cells, such as human neuroblastoma SH-SY5Y cells [17].
In addition, over-expression of NTE arrested COS7 cells at
G2/M phase, yet was not associated with cell cycle arrest at
a particular phase in SH-SY5Y cells [17]. In the present
study, we used synchronous HeLa cells to study the regu-
lation of NTE during the cell cycle progression. In addi-
tion, the role of NTE in cell proliferation was further




Human cancer cell line HeLa S3 was purchased from the
Cell Center of Chinese Academy of Medical Sciences
(Beijing, China). pGenesil-1 plasmid was purchased from
Wuhan Genesil Biotechnology Co., Ltd (Wuhan, China).
TRIzol and the transfection reagent Lipofectamine 2000
were purchased from Invitrogen (Groningen, The Netherlands).
First-strand cDNA Synthesis Kit (ReverTra Ace-a-TM) for
RT-PCR reaction were purchased from Toyobo Co., Ltd
(Osaka, Japan). Ex TaqTM DNA polymerase was purchase
from Takara (Dalian, China). Cell culture reagents,
cycloheximide (CHX), DEPC, epoxomicin, G418, parao-
xon, propidium iodide (PI), RNase A, PC and GPC stan-
dards, thymidine were obtained from Sigma (St. Louis,
MO, USA). Protein A/G Agarose, NTE polyclonal anti-
body, mouse anti-actin monoclonal antibody, rabbit anti-
ubiquitin polyclonal antibody, goat anti-rabbit IgG HRP
and goat anti-mouse IgG HRP were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA, USA). Enhanced
chemiluminescence (ECL) reagents were obtained from
Pierce Biotechnology (Rockford, IL, USA). Mipafox and
phenyl valerate (PV) were synthesized in our laboratory as
described by Johnson [18]. Silica gel 60 F254 plates
(20 9 20 cm, 0.25 mm thick) were purchased from Merck
(Germany).
Cell culture and synchronization
HeLa cells were grown and maintained in Dulbecco’s
modified Eagle’s medium (DMEM) with 10% fetal bovine
serum and 100 U of penicillin-streptomycin. Incubations
were carried out at 37C in a humidified atmosphere of 5%
CO2/95% air. To obtain populations of cells in different
phases, HeLa cells were arrested by double thymidine
block as described previously [19]. Cells were blocked for
18 h with 2 mM thymidine, released for 9 h by washing
out the thymidine, and then blocked again with 2 mM
thymidine for 17 h to arrest all the cells at the late G1
phase. The cells were released by washing out the thymi-
dine and progressed through S and mitosis synchronously.
The cell cycle position of the cells was determined by PI
staining and flow cytometry.
Construction of DNA vector-based RNA
interference plasmids
shRNA-NTE target sites were selected according to previous
reported small interfering RNA targeted against NTE gene
[6]. The shRNA inserts, containing selected 19-nt coding
sequences, followed by a 9-nt spacer, an inverted repeat of
the coding sequence, plus 5 Ts, were generated as doubles
stranded DNAs with BamH I and Hind III sites, and then
cloned into plasmid pGenesil-1. The corresponding oligos





A nonfunctional scrambled shRNA was constructed as a
negative control, which contains nucleotide substitutions at
the 19-nt targeting sequence of shRNA. The corresponding
oligos for generating this scrambled shRNA control were
50-GATCCCCGGAGTTAGGCGTAGTCGAATTCAAGA
GATTCGACTACGCCTAACTCCTTTTTGGAAA-30 and




constructs were verified by DNA sequencing.
Creation of stable cell clones
Constructs were transfected into HeLa cells using lipo-
fectamine 2000 and selected with 500 lg/ml G418 for
3 weeks. Positive clones were confirmed by western blot-
ting and NTE activity assay. The positive cell clones were
maintained in normal medium containing 200 lg/ml G418.
Treatment of cells with epoxomicin
Epoxomicin was dissolved in DMSO. Cells grown in
6-well plates to 70–80% confluence were incubated with
10 nM epoxomicin for 24 h and carrier DMSO as a control.
In these experiments, 30 lM CHX was added to the cells to
avoid the effects of ongoing protein synthesis.
Western blotting
Cells were trypsinized, washed twice with ice-cold phos-
phate-buffered saline (PBS), and harvested in cell lysis
buffer (50 mM Tris pH 7.5, 0.3 M NaCl, 5 mM EGTA,
1 mM EDTA, 0.5% Triton X-100, 0.5% NP40) containing
the protease inhibitor cocktail (Huatesheng Biotech,
Fushun, Liaoning, China). Cell lysates were briefly ultra-
sonicated, and clarified by centrifugation at 12000 9 g for
10 min at 4C. The supernatants were collected for further
experiments. Protein concentration was determined accord-
ing to the method of Lowry et al. (1951) using bovine
albumin serum as a standard [20]. The protein samples were
electrophoresed on 7.5% SDS-polyacrylamide gels, and then
transferred to Hybond ECL nitrocellulose membrane
(Amersham Pharmacia Biotech, Arlington Heights, IL,
USA). Membranes were blocked with 19 Tris-buffered
saline (TBS) containing 0.05% Tween 20 and 5% nonfat dry
milk for at least 1 h at room temperature, and incubated with
primary antibodies (diluted 1:1000), and then with appro-
priate secondary antibodies conjugated to horseradish per-
oxidase (diluted 1:2000). Immunoreactive bands were
detected with ChemiDocXRS (Bio-Rad, Hercules, CA,
USA) using standard ECL reagents (Pierce Biotechnology,
Rockford, IL, USA).
Co-immunoprecipitation assays
Cells were treated with epoxomicin and then rinsed three
times with ice-cold PBS and lysed in the lysis buffer
(50 mM Tris, pH 7.5, 1% NP-40, 0.5% Na3VO4, 150 mM
NaCl, 1 mM EDTA). For immunoprecipitation, the cell
lysates were incubated with anti-NTE antibody, and rotated
at 4C for 4 h. Protein A/G Agarosebeads were used to
immobilize antibody-bound proteins. Immunoprecipitates
were washed three times with lysis buffer and resuspended
in SDS-PAGE loading buffer for immunoblotting analysis
with anti-NTE and anti-ubiquitin antibody.
Reverse transcription–polymerase chain
reaction of NTE
Total RNA from cultured cells was isolated using TRIzol
reagent according to the manufacturer’s directions and
quantified spectrophotometrically after DNase I treatment.
The total RNA (1 lg) of each sample was reverse transcribed
using the First-strand cDNA Synthesis Kit (ReverTra Ace-
a-TM) in a final volume of 20 ll, according to the manufac-
turer’s instructions. The polymerase chain reaction (PCR)
analyses were then performed on the aliquots of the cDNA
preparations to detect NTE and GAPDH gene expression
using a thermal cycler. The reactions were carried out in a
volume of 25 ll containing (final concentration) 2.5 U of Ex
TaqTM DNA polymerase, 0.2 mM deoxyribonucleoside tri-
phosphates (dNTPs), 19 reaction buffer and 100 pmol of
specific primers. Specific forward and reverse primers for
NTE were 50-TTGTCTGACAGAGTATGAGGA-30 and
50-TCGTTGCCGGAGAATCGACT-30 respectively, which
amplified a 128-bp fragment. Specific sense and antisense
primers for GAPDH were 50-ATGCTGGCGCTGAGT
ACGTC-30 and 50-GGTCATGAGTCCTTCCACGATA-30
respectively and amplified GAPDH sequence with 264 bp in
length. The PCR reactions were denatured at 94C for 4 min,
followed by 30 cycles of amplification at 94C 20 s, 56C
20 s, 72C 20 s, and finally extended at 72C for 10 min. By
2.5% agarose gel electrophoresis and ethidium bromide
staining, the PCR products were detected with Chemi-
DocXRS (Bio-Rad, Hercules, CA, USA) under ultraviolet
irradiation.
NTE activity assay
The cells were harvested after rinsed with phosphate-
buffered saline (PBS). Aliquots of the pellets were
resuspended in TE buffer (50 mM Tris-HCl, 0.2 mM
EDTA, pH 8.0), homogenized and centrifuged at
100 9 g at 4C for 2 min. NTE activity in the superna-
tant fraction was determined from colorimetric assay of
the phenol formed by the absorbance difference for PV
hydrolysis between samples exposed to 40 lM paraoxon
and those with both 40 lM paraoxon plus 50 lM mipa-
fox [18] according to the modified method for reduced
volume microassay [21].
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MTT assay
Cells were seeded in 96-well plate and after 24-h cell
proliferation was measured by the MTT assay according to
Lu et al. at the indicated time [22].
Flow cytometry analysis
Cell cycle analysis was carried out with a minor modifi-
cation according to the method described by Zhu et al. [23].
Cells were harvested by trypsinization, centrifuged at
2000 rpm for 5 min, washed in cold PBS, and fixed over-
night in 75% cold ethanol, digested with 20 lg/ml RNase
A and stained with 50 lg/ml PI. The cells were then sub-
jected to flow cytometric analysis on a FACScan (Becton
Dickinson Company, Franklin Lakes, NJ, USA).
Quantification of the amount of PC and GPC
PC and GPC were extracted from cells according to the
method of Bligh and Dyer with some modifications [24].
Separation of phospholipids was achieved by one-dimen-
sional TLC on silica gel 60 plates using chloroform/
methanol/acetic acid/acetone/water (40/25/7/4/2, v/v) as
the solvent [25]. The choline metabolites were fractionated
by TLC in methanol/0.6% NaCl/25%aqueous ammonia
(1/1/0.1, v/v) [26]. The individual phospholipids and cho-
line metabolites were visualized on TLC plates by staining
with iodine vapor. The bands corresponding to PC and
GPC were scraped into glass tubes for quantification. The
PC and GPC levels were quantified by measuring lipid
phosphorus [27].The amount of PC and GPC was given
using the amount of recovered phosphate in each spot and
the results were expressed of nanomoles or micromoles of
phosphorus per milligram protein.
Statistical analysis
Data were generally expressed as Mean ± standard error
(SE) values. Groups of data were compared by one-way
ANOVA and by post-hoc analysis using Student-Keuls
method. A difference between means was considered sig-
nificant at P \ 0.05.
Results
NTE was a cell-cycle regulated protein
To investigate whether NTE is a cell cycle-dependent
protein, it is necessary to obtain a population of synchro-
nous cells at different phases. HeLa cells were chosen
because they arrest efficiently and most cells reenter the
cell cycle and progress synchronously through S phase and
mitosis after a double thymidine block. As shown in
Fig. 1a, using a double thymidine block, more than 85% of
the cells were arrested at G1 stage. After releasing the
HeLa cells from the thymidine block, the cells progress
through S phase synchronously, as assessed by flow
Fig. 1 NTE activity, protein and mRNA levels during the cell cycle
progression. HeLa cells were seeded in 10-cm dishes at a density of
5 9 105 per dish and synchronized by double thymidine blocks (a).
Asynchronous normal and synchronized cells at the stage of G1, S and
G2/M, were collected for FACS analysis. NTE activity (b), protein
content (c) and mRNA level (d) in asynchronous normal (N), G1, S
and G2/M phase cells were assayed. NTE activity in S and G2/M
phase was significantly decreased compared with that in G1 cells,
(n = 3, * P \ 0.05). NTE protein was cell cycle regulated and NTE
mRNA was constant during the cell cycle
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cytometry. More than 85% of the cells progress through S
phase (4 h after releasing) and enter G2/M synchronously
(12 h after releasing).
NTE activity was assayed in synchronized HeLa cells at
G1, S and G2/M phase. NTE activity in asynchronous cells
was 11.2 ± 1.8 nmol/min/protein. As indicated in Fig. 1b,
the cells arrested at the G1 phase had accumulated highest
activity of NTE with 16.4 ± 2.1 nmol/min/protein. NTE
activity was then dropped rapidly as the cells progress syn-
chronously through S and G2/M phases. NTE activity stayed
at medium level at S phase and was lowest at G2/M phase.
The change of NTE activity during the cell cycles may
result from the reduction of NTE content, so then we
analyzed the levels of NTE at G1 and S phase and G2/M
phase by western blotting. As shown in Fig. 1c, large
amounts were detected in G1 cells after the double thy-
midine block. As cells entered S phase, NTE levels
decreased significantly and remained middle. As cells
exited S phase and entered G2/M phase, NTE protein
decreased continuously and was lowest throughout the
whole cell cycle. Together, changes of NTE activity and
protein level at different stages of cell cycle showed that
NTE was a cell-cycle dependent protein.
Whether changes of NTE throughout cell cycle progression
was caused by the transcription of NTE mRNA? NTE mRNA
levels were further analysed during the cell cycle by semi-
quantitative RT-PCR. As shown in Fig. 1d, NTE mRNA
levels were not changed in different phases cells compared
with asynchronous cells, which indicated that NTE mRNA
levels were constant during the cell cycle and suggested that
changes of NTE contents during the cell cycle were results
from the modification at post-transcription level.
Knockdown of NTE by shRNA resulted
in reduction of GPC level
To further investigate the role of NTE in cell prolifera-
tion, a DNA construct was generated to express shRNA
targeted against NTE (shRNA-NTE) and two cell clones
that stably expressing shRNA-NTE was created, which
were named as shNTE A and shNTE B. Western blotting
results showed that NTE levels in shNTE A and shNTE
B were reduced compared with that in control cells
expressing the nonfunctional scrambled shRNA (Fig. 2a).
Further, NTE activity in shNTE A and shNTE B was
assayed. As shown in Fig. 2b, NTE activity in shNTE A
and shNTE B was 2.1 ± 0.4 and 3.2 ± 0.6 nmol/min/
protein respectively, which was 18.8 and 28.6% of the
control cells. Moreover, NTE mRNA levels in shNTE A
and shNTE B were detected to be significantly reduced
by semi-quantitative RT-PCR (Fig. 2c), which demon-
strated that shRNA-NTE efficiently and specifically
inhibited the expression of NTE at a post-transcription
level.
As a novel phospholipase B, NTE deacylates PC to
GPC and is proposed to play a role in phospholipid
homeostasis in mammalian cells. So, the amount of
PC and GPC in shNTE A and shNTE B was further
assayed. As indicated in Table 1, in the control cells, the
amount of PC and GPC was 85.28 ± 7.21 and 25.51 ±
3.21 nmol/mg protein respectively. As expected, GPC in
shNTE A and shNTE B was significantly decreased to
12.28 ± 2.61 and 15.58 ± 2.92 nmol/mg protein. How-
ever, PC level was not affected compared with the control
cells.
Fig. 2 Knockdown of NTE in HeLa cells. a Representative immu-
noblots of NTE expression levels in HeLa cells stably expressing
control shRNA (C) and shRNA to target NTE mRNA (shNTE A and
shNTE B). The expression of actin was protein loading control.
b Quantitative analysis of basal in situ NTE activity. NTE activity
was significantly decreased in shNTE A and shNTE B cells compared
with control cells (n = 3, * P \ 0.05). c Representative RT-PCR of
NTE and GAPDH mRNA expression levels in control, shNTE A and
shNTE B cells, the expression level of GAPDH mRNA as loading
control
Table 1 Effect of NTE reduction on the amount of PC and GPC
in Hela cells
PC (nmol/mg protein) GPC (nmol/mg protein)
Control 85.28 ± 7.21 25.51 ± 3.21
shNTE A 82.56 ± 8.71 12.28 ± 2.61*
shNTE B 86.56 ± 6.71 15.58 ± 2.92*
PC and GPC levels in shNTE A and shNTE B cells were compared
with those in control cells. n = 3, * P \ 0.05
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Suppression of NTE did not affect cell cycle
progression
Previous studies showed that over-expression of NTE
increased a relatively modest degree GPC production and
inhibited normal cell division [6, 17], the role of NTE in cell
proliferation was further investigated by MTT assay in the
cell clones stably expressing shRNA-NTE, shNTE A and
shNTE B. As shown in Fig. 3a, at the indicated time no
significant difference of MTT reduction was observed
between in the control cells and in the two stable cell clones,
which suggested that knockdown of NTE did not inhibit cell
proliferation. Moreover, flow cytometric analysis in shNTE
A and shNTE B indicated that cell cycle progression was
not affected by suppression of NTE (Fig. 3b).
NTE was degraded by the ubiquitin-proteasome
pathway
To determine whether NTE is degraded by the proteasome
pathway, we assessed the effect of a selective proteasome
inhibitor, epoxomicin, on NTE protein clearance [28, 29].
We observed that the proteasome inhibitor treatment pro-
moted the accumulation of NTE protein, which was
increased by 0.5-fold after 24-h incubation (Fig. 4, a
and b). The accumulation of the NTE protein by epox-
omicin was not due to increased protein synthesis for the
presence of CHX. Furthermore, we tested that the possi-
bility that the levels of NTE protein are regulated through
ubiquitin-mediated proteolysis. The cells were treated with
epoxomicin and tracked NTE ubiquitylation by immuno-
blot. (Fig. 4c, input). Immunoblotting for NTE showed a
ladder-like pattern. To determine whether the ladder-like
modification was due to ubiquitylation, we immunopre-
cipitated with NTE antibody after denaturing the sample
and blotted the immunoprecipitates with anti-NTE and
anti-ubiquitin antibodies (Fig. 4c, HA IP).The immuno-
precipitates were recognized by anti-ubiquitin antibody in a
ladderlike pattern, indicating that NTE is polyubiquitylated
(Fig. 4c, NTE IP/Ub blot). These results together indicated
that NTE was degraded by the ubiquitin-proteasome
pathway.
Discussion
As a novel PLB, NTE is not only primary present in ner-
vous system but also in a variety of non-neural tissues
Fig. 3 Effect of NTE knockdown on HeLa cell proliferation. a Cell
viability was determined at indicated times using MTT assay in control,
shNTE A and shNTE B cells. n = 3. b Control, shNTE A and shNTE B
cells were collected and analysed for DNA content by propidium iodide
staining and flow cytometry. Percent of cell population at different
stages in the cells was shown in corresponding DNA histogram. Data
were representative of an independent experiment. Similar results were
obtained in three different independent experiments
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including intestine, placenta, lymphocytes, kidney, liver
and testicle [9, 30]. Furthermore, the existence of homo-
logues of NTE in yeast and flies suggests that NTE may be
involved in a fundamental process common to cells from
yeast to mammal [31]. In the present study, the role of NTE
in cell growth in HeLa cell was first investigated by RNA
interference as a widely used strategy [32]. The results
showed that NTE was not essential for HeLa cell prolif-
eration, although over-expression of NTE inhibited cell
division [6, 17].
In yeast, the putative NTE homologue YML059c is not
essential for cell viability under a variety of conditions [6].
Although complete inactivation of mouse NTE gene
resulted in embryonic lethality at embryonic day 9 (E9),
growth retardation of mouse NTE-deletion embryos at E7.5
did not reflect impaired cell proliferation [10]. Reduction
of NTE did not affect cell proliferation may result from no
change of PC amount, though GPC level was decreased.
The effect of NTE on PC and GPC levels may suggest that
it may play a role under specific conditions, such as reg-
ulation of osmoprotective synthesis of GPC in response to
high NaCl in renal cells and PC homeostasis in response to
high temperature and choline in yeast [33, 34].
In the present study, we chose the well-studied epithelial
cell line, HeLa S3, derived from a cervical carcinoma,
specifically because a high degree of synchrony can be
achieved with diverse methods [19] and as a usual in vitro
model to identify genes periodically expressed in the
human cell cycle [35]. HeLa cells can be synchronized so
that 85% of the cells reenter the cell cycle as detected by
flow cytometric analysis. NTE was first identified as a cell
cycle-regulated protein. The homeostasis between synthe-
sis and turnover of PC is required for cell division and
creation of new membranes [12]. The amount of PC is not
solely controlled by the expression of CCT and PC
turnover is another key player in PC homeostasis during
the cell cycle [12]. Turnover is rapid during G1 and
decreases during S phase to coordinate PC synthesis and
membrane formation [12, 36], thus changes of NTE may
contribute to the regulation of PC amount during cell cycle.
Although NTE was found to be cell cycle regulated,
NTE mRNA levels were constant during the cell cycle as
detected by semi-quantitative RT-PCR, which was con-
sistent with the previous result by DNA microarray [35].
So, the regulation of NTE at post-transcription level may
play a role in control of NTE during the cell cycle. Pre-
liminary bioinformatics analysis of NTE sequence showed
that there was a sequence (R-V-T-F-L-A-L-H-N: amino
acids 276–284) within the putative regulatory domain,
which was similar to the destruction box (D-box) com-
posed of the consensus sequence R-X-X-L-X-X-X-X-N.
The D-box is known recognition signal found in substrates
that are degraded by the ubiquitin-proteasome pathway
(UPP) [37]. In fact, NTE was demonstrated to be degraded
by UPP. The activation of cyclin-dependent kinases
(CDKs) is a driving force of the cell cycle and the activities
of CDKs are controlled by the ubiquitin-mediated prote-
olysis of key regulators such as cyclins and CDK inhibitors
[38]. As such, the ubiquitin-mediated proteolysis of NTE
may be present during the cell cycle.
In summary, NTE was for the first time found to be a
cell cycle-regulated protein and the modification at post-
transcription level, such as UPP, was proposed to play a
role in the control of NTE during the cell cycle. However,
knockdown of NTE decreased GPC level, but did not
change PC content or cell cycle progression.
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